Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
06/2005
06/23/2005DE102004053281A1 New mesogenic S-perfluoroalkyl-sulfimide or -sulfoximide compounds, useful in liquid crystal and electro-optical display devices
06/22/2005EP1542674A1 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof
06/22/2005EP1230207B1 Metathesis syntheses of pheromones or their components
06/22/2005EP1024695B1 Fungicide comprising 4-methyl-6-pentyl-2h-pyran-2-one
06/22/2005CN1630555A Hydroxylation of beta-dicarbonyls with zirconium catalysts
06/22/2005CN1630504A Sunscreen compositions as well as dihydropyridines and dihydropyranes
06/16/2005WO2005054267A1 Glycosylated triketide delta lactones
06/16/2005WO2005053631A1 Microcapsules with uv filter activity and process for producing them
06/16/2005US20050131044 Small molecule inhibitors of necrosis
06/16/2005DE10352659A1 Verfahren zur Herstellung von Statinen Process for the preparation of statins
06/16/2005CA2547229A1 Glycosylated triketide delta lactones
06/15/2005EP1539962A1 Polyene polyketides and methods of production
06/15/2005EP1539727A2 Compounds, compositions, and methods
06/15/2005EP1539686A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/15/2005EP1305301B1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
06/15/2005EP1028963B1 Novel substituted phenyl keto enols
06/15/2005CN1626527A Pyran derivative, method for manufacturing the same, and light-emitting element containing the pyran derivative
06/15/2005CN1626492A Hydrogenant process
06/15/2005CN1206363C Process for obtaining of HMG-CO a reductase inhibitors of high purify
06/15/2005CN1206218C Aryl phenyl substituted cyclic ketoenols
06/14/2005US6906204 Processing method of lactionization in the preparation of statins
06/14/2005US6906085 Tetrahydropyran derivatives as neurokinin receptor antagonists
06/14/2005US6906051 Viricides, fungicides, microbiocides, osteoporosis
06/14/2005US6906007 Insecticides, miticides
06/14/2005CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/09/2005US20050124641 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
06/09/2005US20050124555 Azulene derivatives and salts thereof
06/09/2005US20050124498 Halobenzyl substituted phenylaceto esters and amides and use thereof for prevention of harmful organisms
06/09/2005DE68918191C5 Verfahren zur Lactonisierung von Mevinsäuren und deren Analogen. A method for lactonization of Mevinsäuren and their analogs.
06/09/2005DE10351646A1 2-Halogen-6-alkyl-phenyl substituierte spirocyclische Tetramsäure-Derivate 2-halo-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005CN1625559A Novel compounds that inhibit factor Xa activity
06/08/2005CN1625408A Improved kavalactone profile
06/08/2005CN1205199C Perfume parent
06/02/2005WO2005049599A1 Method of efficiently producing ascopyrone p
06/02/2005US20050119343 Crystalline form; inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase; for oral administration
06/02/2005US20050119322 Phorboxazole derivatives for treating cancer
06/01/2005EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
06/01/2005EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/01/2005EP1248761A4 Compounds which mimic the chemical and biological properties of discodermolide
06/01/2005EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
05/2005
05/31/2005US6900357 Direct, enantioselective aldol coupling of aldehydes using chiral organic catalysts
05/31/2005US6900341 Substituted phenylketoenols
05/31/2005US6900244 Controlling lipid, cholesterol metabolism; anticholesterol agents
05/26/2005WO2005047276A2 Method for the production of statins
05/26/2005WO2005047236A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
05/26/2005WO2005047223A1 Process for the preparation of aliphatic primary alcohols and related intermediates in such process
05/26/2005US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid
05/26/2005US20050113346 making sulfur compounds such as 2-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-N-hydroxy-3-methyl -butyramide, used as tumor necrosis factor-alpha converting enzyme (TACE) inhibitors, for prophylaxis of rheumatic diseases, sepsis or inflammation
05/26/2005CA2545316A1 Process for the preparation of statins
05/25/2005EP1533308A2 A process for producing a simvastatin precursor
05/25/2005EP1533307A1 Process for producing tetrahydropyran-4-ol, intermediate therefor, and process for producing the same
05/25/2005EP1532124A1 Novel compounds
05/25/2005EP1054993B1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
05/24/2005US6897210 Anticancer agents; antiarthritic agents
05/19/2005WO2005044796A1 2-halogen-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives
05/19/2005WO2005044795A1 Process for the preparation of ccr-2 antagonist
05/19/2005WO2005028429A3 Haloalkyl containing compounds as cysteine protease inhibitors
05/19/2005WO2005024025A8 Polyene polyketides and methods of production
05/19/2005WO2005012220A9 Cycloalkylidene compounds as modulators of estrogen receptor
05/19/2005WO2004064745A3 Method of preparation of heterocyclic molecules with pharmaceutical pharmaceutical excipient cosmeceutical agrochemical and industrial uses
05/19/2005US20050107248 Metallic catalysts for chemo-, regio-and stereoselective reactions, and corresponding precursors
05/19/2005CA2544537A1 2-halogen-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives
05/18/2005EP1530462A1 1-phenyl-2-dimethylaminomethyl cyclohexane compounds used for the therapy of depressive symptoms, pain, and incontinence
05/18/2005EP1250047B9 Herbicidal composition
05/18/2005EP1224195B1 C-aryl glucoside sglt2 inhibitors
05/18/2005CN1616432A Compound, its use and pharmaceutical compositions comprising same
05/18/2005CN1616381A Process for preparing Erigeron breviscapus active component
05/18/2005CN1202104C 2-phenylpyran-4-one derivatives
05/18/2005CN1202093C Substituted heterocyclic compound
05/17/2005US6894185 Substituted chiral allosteric hemoglobin modifiers
05/17/2005US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides
05/12/2005WO2005042521A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
05/12/2005WO2003074496A8 Halobenzyl substituted phenylaceto esters and amides and use thereof for prevention of harmful organisms
05/12/2005WO2003006454A8 Heterocyclic carboxamides and their use as fungicides
05/12/2005US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/12/2005US20050101574 Parathyroid hormone production inhibitors containing vitamin d3 derivatives
05/12/2005CA2543715A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
05/11/2005EP1165541B1 Dimeric compounds and as inhibitors of neuraminidase
05/11/2005CN1200936C Pyrone compounds and their use
05/11/2005CN1200699C Anthracyclinone derivatives and their use in amyloidosis
05/10/2005US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1
05/10/2005US6890932 Anthranilic acid derivative
05/10/2005US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/10/2005US6890885 Herbicidal composition
05/06/2005WO2005040147A1 Antitumor agent
05/06/2005WO2005040138A1 Substituted benzylaminoalkylene heterocycles
05/06/2005WO2005040107A2 Methods for making simvastatin and intermediates
05/06/2005WO2005040087A1 Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters
05/06/2005CA2543348A1 Methods for making simvastatin and intermediates
05/06/2005CA2542695A1 Substituted benzylaminoalkylene heterocycles
05/06/2005CA2541843A1 Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters
05/05/2005US20050096384 Compounds and methods for treating breast cancer and other diseases
05/04/2005EP1527062A1 Tetrahydropyran derivatives and their use as therapeutic agents
05/04/2005CN1612872A Process for the preparation of simvastatin
05/03/2005CA2133337C Compounds useful for treating allergic or inflammatory diseases
04/2005
04/28/2005WO2005037809A1 Substituted aryl cycloalkanol derivatives and methods of their use
04/28/2005WO2005037283A1 Fused-aryl and heteroaryl derivatives and methods of their use
04/28/2005WO2005037279A1 1- 2’ (1, 4’-biperidin-1’-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms
04/28/2005WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms)
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 129